Technology News and Research

RSS

Processing patents sped up by European research

Processing patents is complex and time-consuming. Using semantic web technology, researchers have come up with a powerful tool to process patents faster and better.

12 Apr 2009

Research finds active brown fat in adult humans

Researchers at the Joslin Diabetes Center have demonstrated that adult humans still have a type of "good" fat previously believed to be present only in babies and children.

9 Apr 2009

DNA origami rectangle made with 'bottom-up' construction approach

The construction of complex man-made objects--a car, for example, or even a pizza--almost invariably entails what are known as "top-down" processes, in which the structure and order of the thing being built is imposed from the outside (say, by an automobile assembly line, or the hands of the pizza maker).

9 Apr 2009

Telemonitoring changes the working practice of cardiac nurses

The 9th Annual Spring Meeting of the European Society of Cardiology Council on Cardiovascular Nursing and Allied Professions (CCNAP), organised in cooperation with the Irish Nurses Cardiovascular Association (INCA), is being held at the Royal Dublin Society, Dublin, Ireland, on 24-25 April.

8 Apr 2009

FDA to review 25 medical devices marketed prior to 1976

The FDA today announced that manufacturers of 25 types of medical devices marketed prior to 1976 must submit safety and effectiveness information to the agency so that it may evaluate the risk level for each device type.

8 Apr 2009

MRI-based method holds promise for predicting treatment outcomes in patients with atrial fibrillation

University of Utah researchers have found that delayed-enhancement magnetic resonance imaging (DE-MRI) holds promise for predicting treatment outcomes and measuring disease progression for patients with atrial fibrillation (AF), a little known heart rhythm disorder that affects more than 3.5 million Americans and causes more than 66,000 deaths a year.

8 Apr 2009

New nanostructured biosensors

Research and industry are increasingly exploiting the potential of aptamers.

8 Apr 2009

Digital photo album puts focus on kids' health

Modern moms and dads snap thousands of photos, recording every drooling smile and flailing attempt to crawl.

8 Apr 2009

Antibiotics could treat cystic fibrosis, other genetic diseases

By modifying the properties of the common antibiotic gentamicin, researchers at the Technion-Israel Institute of Technology have developed what could become an effective treatment for many human genetic diseases, including cystic fibrosis (CF), Duchenne muscular dystrophy, Usher Syndrome and numerous cancers.

8 Apr 2009

New type of probe enables visualization of single ribonucleic acid

Biomedical engineers have developed a new type of probe that allows them to visualize single ribonucleic acid (RNA) molecules within live cells more easily than existing methods.

6 Apr 2009

Mass spectrometry technique analyzes defensive chemicals on seaweed surfaces for potential drugs

A new analytical technique is helping scientists learn how organisms as simple as seaweed can mount complex chemical defenses to protect themselves from microbial threats such as fungus.

6 Apr 2009

Helicos BioSciences releases transcriptome sequencing datasets as open access

Helicos BioSciences has announced the release of transcriptome sequencing (RNA-Seq) datasets on the HeliSphere Technology Center, the company's open access Web site for sharing Helicos datasets and bioinformatics software tools.

6 Apr 2009

Celsion announces promising trial results for ThermoDox in breast cancer

Celsion Corporation has announced that promising Phase I clinical results evaluating ThermoDox for the treatment of recurrent chest wall (RCW) breast cancer were presented by Duke University investigators on Sunday, April 5 at the 2009 Annual Meeting of the Society for Thermal Medicine (STM) in Tucson, Arizona.

6 Apr 2009

GAO official names first 13 members of HIT Policy Advisory Committee

Government Accountability Office acting Comptroller General Gene Dodaro last week named 13 members to a policy committee on health care information technology established under the federal economic stimulus package, CongressDaily reports.

6 Apr 2009

Nanobiotix reports 'proof of concept' for use of nanoparticles in treating glioblastoma multiforme

Nanobiotix has announced that an independent preclinical study has validated the applicability of using its nanoparticles-nanoPDT-to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the Company focuses development efforts on its nanoXray technology.

6 Apr 2009

Telehealth technology will help seniors and save billions!

The partnership of two of the biggest companies worldwide could have major implications for healthcare in the future, particularly for those living in rural or remote communities.

6 Apr 2009

Zosano Pharma presents positive results for needle-free osteoporosis therapy

Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, has presented positive results from its phase 2 study of the ZP-PTH rapid delivery patch for the treatment of osteoporosis at the 8th International Symposium on Osteoporosis in Washington, D.C.

6 Apr 2009

Pre-cancer screening with urine samples

Dr. Yinfa Ma has developed a method for pre-cancer screening that uses urine samples for detection.

6 Apr 2009

Brain scan-assisted diagnosis for post-traumatic stress disorder a step closer to reality

Florence, Italy: Preliminary research examining the difference in brain activity between soldiers with post-traumatic stress disorder and those without it moves scientists a step closer to the possibility of being able one day to use brain scans to help diagnose the condition.

6 Apr 2009

Monoclonal antibody cancer therapy

The strategy of using monoclonal antibodies for cancer treatment was first described in the late 1970s with the promise that they could be developed into therapies that were highly specific to cancer cells, killing them with few or no side effects.

6 Apr 2009